AbbVie raises profit forecast after Humira, newer drugs drive results beat

The logo for AbbVie is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, New York, U.S., November 17, 2021. REUTERS/Andrew Kelly/File Photo Acquire Licensing Rights Oct 27 (Reuters) - AbbVie (ABBV.N) on Friday raised its annual profit forecast after beating quarterly…#abbvie #newyorkcity #humira #sandoz #amgen #boehringeringelheim #rinvoq #imbruvica
Source: Reuters: Health - Category: Consumer Health News Source Type: news